SCHEMBL7287003

SCHEMBL7287003

O=C(O)C[C@@H]1C[C@@H](CNC(=O)c2ccc3c(c2)CCNCC3)N(CCCc2ccccc2)C1=O

nearest known ligand 0.43

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 11/20 0.43
ITGA2B P08514 9/20 0.43
ALDH1A1 P00352 1/20 0.39
TSHR P16473 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ACHE P22303 1/20 0.39
MCHR1 Q99705 1/20 0.39
HTR1A P08908 2/20 0.38
MTNR1A P48039 1/20 0.37
ITGAV P06756 3/20 0.37
DRD4 P21917 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7277667 0.95 ITGB3 (0.41) ITGB3ITGA2BALDH1A1TSHRSMN1; SMN2
SCHEMBL7277328 0.92 ITGB3 (0.49) ITGB3ITGA2BALDH1A1TSHRSMN1; SMN2
SCHEMBL7284870 0.90 ITGB3 (0.41) ITGB3ITGA2BALDH1A1TSHRSMN1; SMN2
SCHEMBL7275380 0.87 ITGB3 (0.47) ITGB3ITGA2BALDH1A1TSHRSMN1; SMN2
SCHEMBL9251785 0.86 TMPRSS2 (0.41) ITGB3ITGA2BHTR1AITGAV
SCHEMBL7275263 0.86 TMPRSS2 (0.41) ITGB3ITGA2BHTR1AITGAV
SCHEMBL7274663 0.86 ITGB3 (0.40) ITGB3ITGA2BALDH1A1TSHRSMN1; SMN2
SCHEMBL7277666 0.85 TMPRSS2 (0.41) ITGB3ITGA2BHTR1AITGAV
SCHEMBL7275558 0.84 MTNR1A (0.38) ITGB3ITGA2BHTR1AMTNR1AITGAV
SCHEMBL7277147 0.84 ASAH1 (0.42) ITGB3ITGA2BALDH1A1TSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5455348-A Anticoagulants Thomae, Karl (DE) 1995-10-03 US disclosed
EP-0528369-A2 Cyclic imino derivatives, pharmaceutical compositions containing them and process for their preparation Dr. Karl Thomae GmbH (DE) 1993-02-24 EP disclosed